Measuring limb movement in achondroplasia and hypochondroplasia
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This study is tracking how people with achondroplasia or hypochondroplasia move their limbs in daily life using a small wearable device. The information will help doctors better understand these conditions and may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be at least 2 years old (or between 2 and 16 in the UK).
- A genetic test must confirm achondroplasia or hypochondroplasia.
- You or your child must be able to walk on your own for at least 10 meters.
- You must not have other causes of short stature, not be pregnant, and not have recent limb injuries.
- No limb lengthening surgery in the past or planned during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children with hypochondroplasia, a condition that causes short stature. It will look at how the condition changes over time and aims to better understand it, with the goal of finding new treatments.
This trial tests a new medicine for children with achondroplasia (a common form of dwarfism). It aims to see if the drug can improve growth. The study is for children aged 2.5 to under 11 years old who have not started puberty and can walk without help.
This study observes children with hypochondroplasia to learn more about the condition. It does not involve any treatment—just monitoring and data collection to help future research.
This study uses a virtual (online) approach to better understand achondroplasia across all ages. By collecting medical records from people in the US, researchers hope to learn more about the condition and improve care.
This study follows people with achondroplasia to better understand what medical issues happen over time. It may help doctors plan care and recognize patterns earlier.
this study is a long-term extension of the main study for the drug which from Bio? bi? whatever? in the name? by?...????
Hear when a new Achondroplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.